#coronavirus #koronavirus
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2020 – Jul 2025Where it's discussed
-
X / Twitter225 posts
-
News80 articles
-
Reddit20 posts
-
Blogs12 articles
-
Facebook6 posts
-
YouTube2 videos
AI synopsis
What people are saying
Numerous discussions underscore the study's conclusion, with comments indicating that hydroxychloroquine showed no significant benefit over the placebo in preventing COVID-19 among healthcare workers. Phrases like 'no real difference' and 'better results for placebo' showcase a general understanding of the trial's findings. The tone suggests a mix of incredulity and frustration toward ongoing debates about the drug's efficacy, signaling that many have moved on from this topic but are still seeking to clarify facts.
Many discussions convey strong consensus regarding the ineffectiveness of hydroxychloroquine.
While there is interest in the topic, the overall sentiment indicates a general fatigue toward repeated discussions of this study.
Participants often cite specific studies and results, but the engagement depth varies, showing a mix of strong opinions and dismissive responses.
There is a perception that the findings of this study have significant implications for public health and treatment protocols.
Abstract in brief
- The study assessed the effectiveness of hydroxychloroquine as a preventive measure against SARS-CoV-2 infection among healthcare workers exposed to COVID-19.
- The randomized trial involved 132 healthcare workers but was terminated early due to no significant difference in infection rates, showing hydroxychloroquine did not outperform a placebo.
- The primary outcome focused on infection rates via nasopharyngeal swabs, while secondary outcomes examined side effects, treatment discontinuation, and clinical outcomes for those who contracted the virus.
Top posts
Most liked on X and BlueskyRegulators may note please.. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/FPcQ9KVhmD via @JAMAInternalMed part of @JAMANetwork
Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: https://t.co/OECGQE46Zb
@ujualnarayan @drsimonegold Yeah it was done. It was done for mild disease. https://t.co/NzRZtN15Fn It was done for prophylaxis. https://t.co/fvhH9SMC3r No drug was as studied, with so many negative results. HCQ doesn’t work for Covid. End of story.
https://t.co/cWgO6Vi64K #meded #medtwitter
❌ Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/XocgRMwZG8 via @JAMAInternalMed part of @JAMANetwork
All mentions
COVID-19 and Donald Trump's Health: Key Insights
COVID-19 has caught up with President Donald Trump, highlighting the importance of safety measures. Vitamin D sufficiency, with levels at least 30 ng/mL, significantly reduces severe outcomes in COVID-19, suggesting…
6. Segurança e efeitos adversos da H.CQ
RT @TonJeanne: @GValeau @Lojodaskell_ @lonnibesancon @PiedNuke @grok @Nature @Jeannemarie1309 @anglade_nicole 2 encarts non signifiants, ca…
@GValeau @Lojodaskell_ @lonnibesancon @PiedNuke @grok @Nature @Jeannemarie1309 @anglade_nicole 2 encarts non signifiants, capturés au hasard pour faire sachant. 2 premieres etudes encart 1, RAS. https://t.co/awuVQuiHWH Encart 2 sans interet. Un enfant de 6 ieme sait que les notes de reference ne font pas le texte. Passe un test QI, t'as droit a une indemnité handicap.
@Fleurette_0 @ChatSecouriste @VictorSinclair3 @sandrousseau Essais RCT HCQ azythro Tang https://t.co/zeu5LJQfuM Chen (Jun) https://t.co/JcchnBgOKP Boulware (COVID-19 PEP) https://t.co/TgwIVEHanw Ulrich https://t.co/2M8aD2R8A5 Abella (PATCH) https://t.co/4xIctx7b8p
@Carborundu55651 @DrLorieF @Notyour28981739 https://t.co/lOe7kfyCs0
@Carborundu55651 @DrLorieF @Notyour28981739 Clearly it isn't posting those mistakes on purpose hence the retraction. https://t.co/lOe7kfyCs0
@Carborundu55651 @DrLorieF @Notyour28981739 https://t.co/lOe7kfyCs0
@DrLorieF @Notyour28981739 https://t.co/lOe7kfyCs0
@PecanC8 https://t.co/SjlOiZzxKo
@filipe_rafaeli Talvez esse? https://t.co/qRXfYhVahC
@dollynhofazul2 @fazuelliottaru @NielsendoBrasil @MaraboTomas @filipe_rafaeli @DoutorMaravilha Pode ser esse? https://t.co/qRXfYhVahC
@Conspiracybot11 @fazuelliottaru @NielsendoBrasil @MaraboTomas @filipe_rafaeli @DoutorMaravilha https://t.co/qRXfYhVahC
@CKellyUAP HCQ as effective in plcebo im stopping covid https://t.co/pZrmtp99bu
@delasttours Tiens, lis ça et on en reparle après
@brismich1 @mum89000 @MartinZ_uncut @aphm_actu
@jucanabrefa @Sonic_urticant @jejedu67 @MathieuMolimard Celle là, entre autres… https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI
@Zulu18360299 @rabah_larabi @LO974 Une efficacité a la limite de la significativité ca n'existe pas en science med. Soit ca a un benefice soit ca n'est pas le cas. Il y en a plein des RCT qui ne montrent aucune difference avec les controls. https://t.co/YoYlSdUX9Y https://t.co/aocehLemkt https://t.co/7RwxZQ9uKd
@filipe_rafaeli Uma metanálise só deve ser realizada no contexto de uma revisão sistemática. Assim fica fácil, né? Esqueceram de incluir esse estudo de Benjamin et al https://t.co/lKk1NYYQce
Tweeted this in Sept 2020. Disingenuous study published in JAMA IM, sample size too small, young healthy w no known exposure, terminated early w/o meeting enrollment goals, only 4 + PCRs, none sick, in each group, conclusion unjustified https://t.co/fpQ8aZfTBB 1/2 https://t.co/5CLyqcvIa2
@SallyVadar @4554Steevy Ummm.... no. Here are the related JAMA & NEJM papers from RCT's that demonstrate no benefit. And we're still 0-for-ever in terms of curing a viral infection. Prevention & treatment are all we have. https://t.co/UeYYflhUrc https://t.co/7LwOataVG6
@Alterego238 @4554Steevy What about the highlighted section that states; "So HCQ functions as both a vaccine and a cure."? That looks like the author's claim to me. In any case, JAMA and NEJM both published papers related to studies that demonstrated no benefit as a prophylactic. https://t.co/UeYYflhUrc
Did he forget the Viewpoint piece he co-authored in Nov 2020 during lead up to vaccines: https://t.co/UmtMr6FwOD. Where he references (6) deliberately undersized study https://t.co/7eqPr02vIN claiming HCQ doesn’t work. Dishonest argument using whatever bad “research” available. https://t.co/89HLd8NcHI
@AAPSonline Did he forget the Viewpoint piece he co-authored in Nov 2020 during lead up to vaccines: https://t.co/UmtMr6FwOD. Where he references (6) deliberately undersized study https://t.co/7eqPr02vIN claiming HCQ doesn’t work. Dishonest argument using whatever bad “research” available.
@KDMilhoanMD Did he forget the Viewpoint piece he co-authored in Nov 2020 during lead up to vaccines: https://t.co/UmtMr6FwOD. Where he references (6) deliberately undersized study https://t.co/7eqPr02vIN claiming HCQ doesn’t work. Dishonest argument using whatever bad “research” available.
@sudokuvariante @OsonsCauser @humanite_fr Etudes sur l'inefficacité de l'hydroxychloroquine : https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI https://t.co/U4gVGlXfs9 https://t.co/xeEufVzoA9 https://t.co/eIrP7nQZlJ https://t.co/hbTaIWOlXa https://t.co/nY2tJuMhmF
@Mzz_Chelle @burgsey2 @Debsplace63 @CoachSteve11 @BethanyCherisse Both early and pre-exposure show no effect. Yawn. Facts: 1 McCullough: 0 https://t.co/x3Ib8oO0Xz
@marcellotoa @NicolasMauduit @Nain_Portekoi
@Malu45_RJ @freire_roberto "Que tal estudar, ler artigos sérios de médicos renomados no mundo" Todos dizem exatamente o que ele diz: não há eficácia do HCQ contra a COVID-19 -https://t.co/a6a7MuwYWT -https://t.co/J2kJDDH2Vz -https://t.co/NltMf3twXq
@Tsadqiell @Esban_ Etudes sur l'inefficacité de l'hydroxychloroquine : https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI https://t.co/U4gVGlXfs9 https://t.co/xeEufVzoA9 https://t.co/eIrP7nQZlJ https://t.co/hbTaIWOlXa https://t.co/nY2tJuMhmF
@OunetPik @r_cluz @CocoCocoCocoVi1 @clouzeau_b Etudes sur l'inefficacité de l'hydroxychloroquine : https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI https://t.co/U4gVGlXfs9 https://t.co/xeEufVzoA9 https://t.co/eIrP7nQZlJ https://t.co/hbTaIWOlXa https://t.co/nY2tJuMhmF Bonne lecture.
@r_cluz @Lspjerem @CocoCocoCocoVi1 @clouzeau_b sur l'inefficacité de l'hydroxychloroquine : https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI https://t.co/U4gVGlXfs9 https://t.co/xeEufVzoA9 https://t.co/eIrP7nQZlJ https://t.co/hbTaIWOlXa https://t.co/nY2tJuMhmF
@010wijk11 @saskiaveluwe @MarkWendrich @Koffiegeest @vredigewereld @Emanuel15272509 @muumi_tweets @Gielisbedrogen @Poisoni51179073 @mus_nico @Marc_Veld @njmidm @mholkers @ricodevos @Tinuzsz @deBeroepsgroep @JohanvdB8 @MerlotVine @OlifaNT @DocDoorsnee @VaxxDoc " In this double-blind, placebo-controlled randomized clinical trial there was not a significant difference in reverse-transcriptase polymerase chain reaction–confirmed SARS-CoV-2 incidence between HCQ and placebo." https://t.co/rktnKq6IrN 2/2
@NicJoubert81 @MagChange_73 https://t.co/tZJ9Dlto16 https://t.co/m9dA25JHbb https://t.co/eux9Kvkl1X https://t.co/Q9MIkNicWB https://t.co/FEmMM7CR1V
RT @AlastairMcA30: @ujualnarayan @drsimonegold Yeah it was done. It was done for mild disease. https://t.co/NzRZtN15Fn It was done for pro…
@wedietz @gorskon This was a small study and was halted early, but it was not found to prevent COVID. I'm trying to find the other I saw about treating COVID. But the results for placebo and HCQ were very similar. https://t.co/MYcKHQrRY5
@NaZa_on @LazzariAmbrogio @MGrecoMD @vadoaberlino @GiacomoGorini https://t.co/F6Kmd8eBi8 https://t.co/6vjfFRxt23 https://t.co/Xt6OtNx4M7 https://t.co/l46ArRAx26 giusto qualcuno, ma ne è piena la letteratura.
2. https://t.co/0LAQ4nX3Wv no difference (0.3%) 3. https://t.co/HNM3UohGnp better results for placebo 2/2
@lebel1886 @janestaller @TheEUEducator @FishInLake @yesisworld Because hydroxychloriquin turned out to be no more effective than placebo and better treatments were developed. https://t.co/kKcx4fyjQX
@glaco64 @AdventureKachu @Nunenthal •Tang https://t.co/PaohscBSi3 •Chen (Jun) https://t.co/3ErCJ0RoTP •Boulware (COVID-19 PEP) https://t.co/UTDdVXrtEz •Ulrich https://t.co/iSlxrkbgOV •Abella (PATCH) https://t.co/KHH92IXlg8 •Barnabas https://t.co/XpSOKQ7jdZ
@JonathanCagle41 @ElijahSchaffer https://t.co/hZMOl9Xmda https://t.co/VXrWfs6jH2
@OsonsCauser @Thinker_View @LMucchielli https://t.co/1npa1MraZx https://t.co/CHt6RMerLH https://t.co/ebHstUovIp https://t.co/4aldbmMotu https://t.co/e97br8mTRI pas d'azithromycine poubelle.
@SenadorHeinze Se você realmente está tentando se informar sobre o assunto, como afirmou hoje, LEIA: https://t.co/iTZ7GJTOzC https://t.co/PjVVtCMEYr https://t.co/dBbAt5swQe https://t.co/0VVSv3yXDD https://t.co/FIVNKCWVg8 PARE de ser um desinformado e desinformador, senador.
@johnbil81061037 @MarcLobliner @TheMFingCOO https://t.co/0m9VFLApYH
@NMoonitz @DunamisDesi https://t.co/GNAU45LVGi
@fabianogcreton @Adrieli_S https://t.co/uULzd6aQdz Esse aí compila estudos de vários continentes. https://t.co/lQQCVTCpFh Esse é Dr @BenjaminAbella https://t.co/3B5WneWgg7 Deixarei mais um de brinde pra ver como é FÁCIL ACHAR grandes estudos e tudin de 2020. Boa leitura.
@PotsPol @freshnibba1356 @polemistis777 @M8nycFzEHk1SkpL @NickJFuentes https://t.co/DXsr58LvS1
@Joes94CrimeBill @MagChange_73 @JJuteux Essai clinique randomisé en double aveugle, contrôlé par placebo: "There was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19" https://t.co/BWIiKFPAqM
@MagChange_73 @Joes94CrimeBill @JJuteux JAMA https://t.co/Q9MIkNicWB https://t.co/FEmMM7CR1V
RT @the_apex_dawn: @Joes94CrimeBill @VincentJappi @jlkBlackburn Essai clinique randomisé en double aveugle, contrôlé par placebo: "There w…
@Joes94CrimeBill @VincentJappi @jlkBlackburn Essai clinique randomisé en double aveugle, contrôlé par placebo: "There was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19" https://t.co/BWIiKFPAqM
@xnert It's a summary of all the studies he quotes and the problems with them - I thought you might be able to understand it. Send me the link to the JAMA. Can't find him but found other failed HCQ trials. https://t.co/Ns5AjTFfWs
@UzunDr Randomize Kontrollü Bir Çalışma Hidroksiklorokinin COVID-19 Profilaksisinde Faydasız Olduğunu Gösterdi. #koronavirus #COVID19 Türkçe Özet : https://t.co/RDwLQa7BJ0 Orjinal : https://t.co/V53sAyNbJY
neste estudo, a administração diária de #hidroxicloroquina não apresentou benefício quando utilizada como profilaxia pré-exposição para profissionais de saúde expostos a pacientes com #covid19. #CPIdaCovid #CPIdaPandemia https://t.co/5MuSC5K8Wi
@ujualnarayan @drsimonegold Yeah it was done. It was done for mild disease. https://t.co/NzRZtN15Fn It was done for prophylaxis. https://t.co/fvhH9SMC3r No drug was as studied, with so many negative results. HCQ doesn’t work for Covid. End of story.
@paulabarpp @jairmearrependi https://t.co/hTUGF3HVMB https://t.co/us8So2ooWp https://t.co/tNmTvAtIzz https://t.co/qVx4GUpfwE https://t.co/WcpOqVwflO https://t.co/UVjsmYWWit https://t.co/x9BNnah97f https://t.co/L5NmEIhfzw https://t.co/B1WEFQaBS6 https://t.co/paYFffbdP4
@AhoultA @MrZ70914564 @MRvdb @LehmannDrC Ben montrez nous en une ^^ https://t.co/aocehLemkt
@TrumpRussiaTies Thanks for reminding me to see how that worked out
@FredHarris_GC @TomDoubting @ripgustriandos @Flattielover @martuk56 @ThereseOSulliv2 @fuzzytoad @CramerSez @jimaw63 @LadyOfTheOcean1 @hrt6017 @DoctorSavage8 @markblei @OldStudentnow @GuinnBonnie @AbigaiIWesson @chriscr66024638 @Klee34036780 @Thumper18560818 @JDW714 @GailMaga @Lou_SuzyKolb @laylow88861429 @Shopdogg2 @Anti_Liberal3 @WarriorClayton1 @JimmyDeen40 @MinnesotaExpat @TheReelTruth_ @Allie4Christ @chrisg409ubc @IAMISjp @ClaraBell_Cow @scary_brock @r0xie_f0x @Steven_KJV @dermotjm9er @SlimJimJohn1 @JoeSameh @queenicarius @Maria_Not_Annie @Rm1EvoThe3rd @PamelaEdwards @America84895255 @mag_dog2020 @lanny33571893 @kramer_bo @GQPklepto @SpRiNgStR3Am @RoseannaBandan1 https://t.co/GvkGIFEnLn
@Michel88631131 @detetivevsilva @mellziland @NatureComms Comece por estes: https://t.co/IL7DroRHn6 https://t.co/e1L1Pu5pLi https://t.co/Dub4PrplN0 https://t.co/NSTBGyq9bc
@jeanmichel_ac @aventuras_js @fernandoulrich Preguiça de procurar ein... https://t.co/JrOPlyoNV2 https://t.co/biFT8TTqhL https://t.co/9bM8bUZyGE https://t.co/equiqIlEbZ Divirta-se. Boa leitura.
@SimoneSantuelli @artioseaandsky @LaVeritaWeb Parlando di evidenze, il dott. Stramezzi sostiene l'efficacia dell'idrossiclorochina nella fase iniziale, finora non hanno fornito nessun dato a conferma, ma guardando i trial clinici non si vede alcun beneficio contro Covid-19: https://t.co/7aUThTC2gD https://t.co/yQWj28SYz3
@AmauriRicardo5 @philliphonorato @SenadorKajuru https://t.co/skFqWRtUdo
@francopavoni1 @powerpibio @LaVeritaWeb Ci sono anche trial effettuati nella fase iniziale (e ne sono in corso altri) o addirittura come profilassi, nessuno di questi ha rivelato una qualche utilità dell'idrossiclorochina contro Covid-19. https://t.co/7aUThTC2gD https://t.co/JYk6WE4qvJ
@VladiNeri @ferrix88 @rrico_e @razorblack66 @AzzurraBarbuto Se parliamo, ad esempio, di idrossiclorochina somministrata nella fase iniziale nei trial clinici si è dimostrato che non funziona. I medici che sostengono che sia efficace dovrebbero portare le prove di ciò che dicono. https://t.co/7aUThTC2gD https://t.co/yQWj28SYz3
@Senescenza @ferrix88 @rrico_e @razorblack66 @AzzurraBarbuto Le "cure domiciliari" sostengono l'efficacia dell'idrossiclorochina somministrata nella fase iniziale. Nei trial clinici è dimostrato che il farmaco non ha alcun effetto benefico contro Covid-19. https://t.co/yQWj28SYz3 https://t.co/7aUThTC2gD
@Eikour Ce ne sono per tutti i gusti. Tipo questo https://t.co/F5iPFO5cCC O questo https://t.co/sq9FrTg6xP Trattamento precoce, trattamento tardivo, mix dei due, profilassi, metanalisi, quello che volete. Non funziona mai. Saremmo tutti contenti SE funzionasse, ma NON FUN-ZIO-NA
RT @JAMAInternalMed: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers…
RT @JAMAInternalMed: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers…
RT @JAMAInternalMed: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers https://t.co/QxvFqbAIm7
A double-blind random study indicating that Hydroxychloroquine had no effect on preventing exposure to COVID19. #getvaccinated #COVID19 #prevention #herdimmunity #vaccineswork #COVIDprevention #endcovid#wewillovercome #Vaccine #savelives #reduceexposure https://t.co/QLixcvdaJ5 https://t.co/jHqHZ0PNAj
@christophewyns @Erik44187887 @LMucchielli •Abella (PATCH) https://t.co/KHH92IXlg8 •Barnabas https://t.co/XpSOKQ7jdZ •Mitja (BCN PEP-COV2) https://t.co/fhzGSS8wSy •Skipper (COVID-PEP) https://t.co/gsTjgffNMa •Self (ORCHID) https://t.co/MOPGlscUb3
@DzjengisC @mboudry https://t.co/c1pLU7p0Ho
RT @JAMAInternalMed: https://t.co/cWgO6Vi64K #meded #medtwitter
RT @JAMAInternalMed: https://t.co/cWgO6Vi64K #meded #medtwitter
RT @JAMAInternalMed: https://t.co/cWgO6Vi64K #meded #medtwitter
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/rXEslSsgmH via @JAMAInternalMed part of @JAMANetwork https://t.co/PprMzGMFR7 https://t.co/yuFNYu122b
クロロキンを医療従事者に予防投与しても新型コロナ感染を防げず、有害事象がやや多い、という報告。クロロキンは出る幕無し、って感じですね。 https://t.co/6FqEecCcHc @JAMAInternalMed part of @JAMANetworkより
RT @JAMAInternalMed: https://t.co/cWgO6Vi64K #meded #medtwitter
https://t.co/cWgO6Vi64K #meded #medtwitter
@aragon_jb Source https://t.co/sCKjxGtmsy
New study shows #hydroxychloroquine #HCQ useless in preventing #COVID19 https://t.co/kBUFn20SvV
In this study, daily #hydroxychloroquine did not prevent #SARSCoV2 infection in hospital-based #healthcareworkers Find our more from @JAMAInternalMed https://t.co/1dY7ZEEhEo https://t.co/foeca5a5zX
@QQuantity2 @kdgLOVES @Bjornapoor @donaldc58 @ArielCohen37 HCQ data is messy, but this is generally what I’m finding RE prophylaxis. It doesn’t work! But I think the jury may still be out on Ivermectin. In any case, the vaccines are proven and DO work. https://t.co/imdmYU79Eo
Un aporte para los expertos del país (era ironía en caso de no entenderse) https://t.co/8Pt8nUyQ16
Let her rip Brian! @btysonmd @kksheld @DrKellyVictory @stella_immanuel @AAPSonline https://t.co/P9Os0JrIno
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
https://t.co/UrqjcgEMMF
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
@Medecinemadd @matt00087 @EmWilLouis @ju_caz @OJBoyau @MathieuMolimard @amelie_for_you @LacombeKarine1 Ulrich https://t.co/Tl2DpiQQYL Abella (PATCH) https://t.co/AONChQGAS7 Barnabas https://t.co/xjzCUlGtMj Mitja (BCN PEP-COV2) https://t.co/XjPQTtckUS Skipper (COVID-PEP) https://t.co/lTvxdo6EzG Self (ORCHID) https://t.co/YYT97iFiSF
RT @mtrokko2: クロロキンはCOVID減らさない Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Ca…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/2sKxFGf4Pn a través de @JAMAInternalMed part of @JAMANetwork
RT @mtrokko2: クロロキンはCOVID減らさない Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Ca…
RT @mtrokko2: クロロキンはCOVID減らさない Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Ca…
RT @mtrokko2: クロロキンはCOVID減らさない Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Ca…
クロロキンはCOVID減らさない Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/C8Jwbsx6JZ @JAMAInternalMed part of @JAMANetworkより
@Sebco47960604 @WaterTrue @Libre__Dz @raoult_didier •Abella (PATCH) https://t.co/KHH92IXlg8 •Barnabas https://t.co/XpSOKQ7jdZ •Mitja (BCN PEP-COV2) https://t.co/fhzGSS8wSy •Skipper (COVID-PEP) https://t.co/gsTjgffNMa •Self (ORCHID) https://t.co/MOPGlscUb3
@Just4TheCause @MsTrixter @Spitfire_Annie @_mamadeb @LauraDekker1 @mcfunny @LiamKav @IamTybalt79 @Angel_13_Rising @JamesElijahMill @vajra21 @Leighspc @swedishchf @ianfmusgrave @hauxton @TonyBaduy @Michael61479644 @RisetteMD @PaulVCooper1 @TakethatCt @provaxtexan @BronxtheBearFU @KStateTurk @Freeflyfreak1 @emartinez78987 @TinFoilAwards @fuckdictatordan @FormerAntivax @GeoffSchuler @Terrorbyte101 @AndrewLazarus4 @FrankDElia7 @Charitable_Fury @weaponizedword1 @doritmi @FreedomVivian @CLAREEVANS6 @AcornFrances @1_TMF_ @krebiozen @luciandipeso @PriestofBaal @crabb_vicki @Tawdge @Aly_Meek @WendyOrent @jkellyca Of course clinical trials are run in order to test the safety and efficacy of a drug. Research at doi:10.1001/jamainternmed.2020.6319 would once again demonstrate that HCQ was of no benefit in COVID-19 treatment. or prophylaxis
@PLarroque Boulware (COVID-19 PEP) https://t.co/65XVdis0j7 Ulrich https://t.co/Tl2DpiQQYL Abella (PATCH) https://t.co/AONChQGAS7 Barnabas https://t.co/xjzCUlGtMj Mitja (BCN PEP-COV2) https://t.co/XjPQTtckUS Skipper (COVID-PEP) https://t.co/lTvxdo6EzG
In this randomized clinical trial, although limited by early termination, there was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19.https://t.co/0elX9bGbOp
RT @josegallucci: ❌ Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https…
❌ Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/XocgRMwZG8 via @JAMAInternalMed part of @JAMANetwork
@therecount um, as the first author of one of the published RCTs on hydroxychloroquine, I can personally tell you that the evidence of it working for COVID19 prevention or treatment is.... not there. https://t.co/KXBOYeXv7x
New2Trip: Efficacy & Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: Randomized Clinical Trial https://t.co/1AbTab4O39
RT @tripdatabase: New2Trip: Efficacy & Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Wo…
New2Trip: Efficacy & Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: Randomized Clinical Trial https://t.co/1AbTab4O39
New2Trip: Efficacy & Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: Randomized Clinical Trial https://t.co/1AbTab4O39
New2Trip: Efficacy & Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: Randomized Clinical Trial https://t.co/1AbTab4O39
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/1CS5r3Dj9e via @JAMAInternalMed part of @JAMANetwork
RT @mayogastro: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Work… https://t.co/5wMRuHaTLL
RT @mayogastro: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/oPOc1DWHIr vía @JAMAInternalMed part of @JAMANetwork
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial https://t.co/u5pnp7yqAX
RT @TraderAT12: #coronavirus #koronavirus
«Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care...» https://t.co/2kFY6izMhe vía @JAMAInternalMed part of @JAMANetwork
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
RT @TraderAT12: #coronavirus #koronavirus
#coronavirus #koronavirus
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. https://t.co/VUDb3djlpB TLDR: no benefit
#COVID19 #coronavirus #covid #hydroxychloroquine Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. https://t.co/wOYQAax453
RT @atscommunity: Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: h…
RT @atscommunity: Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: h…
RT @atscommunity: Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: h…
RT @atscommunity: Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: h…
RT @atscommunity: Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: h…
Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: https://t.co/OECGQE46Zb
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. https://t.co/VUDb3djlpB TLDR: did not help
RT @PharmaVik: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.…
RT @PharmaVik: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.…
RT @PharmaVik: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.…
Sıtma ilacı faydalı mı zararlı mı tartışma devam ediyor. Doktor, hemşire, acil teknisyeni ve solunum terapistlerine #Corona
Entendi desde o princípio que o tratamento era em combinação com zinco. Cadê o zinco no estudo? Outra conta de chegada? Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis https://t.co/A01JHFwpfI via @JAMAInternalMed part of @JAMANetwork
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial | Infectious Diseases | JAMA Internal Medicine | JAMA Network https://t.co/rhKVZuNGUL
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis RCT finds in hospital-based health care workers, daily hydroxychloroquine did not prevent SARS-CoV-2 infection https://t.co/I0QseVqSzp via @JAMAInternalMed part of @JAMANetwork
RT @drterrysimpson: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https…
RT @drterrysimpson: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/2sXEz2nmk5 via @JAMAInternalMed part of @JAMANetwork
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @medpedshosp: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A…
RT @EpiAA50: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @EpiAA50: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co…
RT @ABsteward: NEW
RT @EpiAA50: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co…
RT @EpiAA50: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co…
RT @ABsteward: NEW
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial https://t.co/jxbPpvLOpO #hcq #Hydroxychloroquine #covid19
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @MdFacep: Hydroxychloroquine shows no benefit in reducing coronavirus infections among health care workers. Efficacy and Safety of Hydr…
RT @frlagarce: Il est possible de faire un essai hcq vs placebo ! Et devinez quoi ? ... Efficacy and Safety of Hydroxychloroquine vs Place…
RT @frlagarce: Il est possible de faire un essai hcq vs placebo ! Et devinez quoi ? ... Efficacy and Safety of Hydroxychloroquine vs Place…
RT @Parvaizkoul: Regulators may note please.. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis…
RT @Parvaizkoul: Regulators may note please.. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis…
RT @AntonioAddis2: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https:…
Est-ce assez clair ? Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial @dr_l_alexandre https://t.co/laIQCnbKRH
Regulators may note please.. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/FPcQ9KVhmD via @JAMAInternalMed part of @JAMANetwork
How many more times does HCQ have to fail in either treating or preventing COVID? /// Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/wfEmXy91r2 via @JAMAInternalMed part of @JAMANetwork
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/TU0q6jHmpC via @JAMAInternalMed part of @JAMANetwork
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers #HealthCare #health #ui via https://t.co/W87dEfXcUv https://t.co/JbscOnT9kX
RT @camilocnn: Nuevo estudio señala inutilidad de hidroxicloroquina. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-expos…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/j3qY1xVDHN via @JAMAInternalMed part of @JAMANetwork
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/ljR8Py9q3n via @JAMAInternalMed part of @JAMANetwork
RT @camilocnn: Nuevo estudio señala inutilidad de hidroxicloroquina. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-expos…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/EmliHY1SBP via @JAMAInternalMed part of @JAMANetwork
RT @camilocnn: Nuevo estudio señala inutilidad de hidroxicloroquina. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-expos…
El uso de HCQ en trabajadores de la salud como profilaxis preexposición NO redujo la transmisión de SARS-CoV-2. JAMA Intern Med. doi:10.1001/jamainternmed.2020.6319
RT @camilocnn: Nuevo estudio señala inutilidad de hidroxicloroquina. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-expos…
September 30, 2020 Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care WorkersA Randomized Clinical Trial https://t.co/PtNTP2LzaZ
Nuevo estudio señala inutilidad de hidroxicloroquina. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial | Infectious Diseases | JAMA Internal Medicine https://t.co/4SxWIX9M73
Among hospital-based health care workers, daily hydroxychloroquine did NOT prevent SARS-CoV-2 infection. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/OUeXS7OlOO via @JAMAInternalMed
RT @josegallucci:
RT @ABsteward: NEW
RT @MJR_5555: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.c…
RT @carpe_diem0820: COVID-19患者の診療にあたる医療従事者が暴露前予防としてヒドロキシクロロキンを8週間毎日服用しても、臨床的な有益性は認められなかった Efficacy and Safety of Hydroxychloroquine vs Pla…
RT @ABsteward: NEW
#Hydroxychloroquine No More Effective Than Placebo in Preventing #COVID19 https://t.co/VgDlIVFAMF & https://t.co/tp54XTzX98 https://t.co/nGIEaEv5sj
Trump is not always factually correct. Hydroxychloroquine does not have a detectable benefit in preventing development of Covid-19 if taken regularly, and has more side-effects than placebo (none fatal). https://t.co/zHgoBZDip9 Trial stopped when futility agreed. n = 132
Abella BS, Jolkovsky EL, Biney BT, et al. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. JAMA Intern Med. Published online September 30, 2020. doi:10.1001/jamainternmed.2020.6319
AR
PK
AA
AM
JM
JG
M
JT
SP
T
SJ
LP
T
LM
KK
JR
PG
SM
H
CS
GB
DS
A
KS
F
AS
AL
R
IF
AL
EM
C
CC
S
SA
T
H
NE
L
B
AW
DB
JM
S
VF
AP
PL
FA
BB
A
ZD
H
EC
MS
つイ
BM
Y
SG
OI
S
MG
MB
D
A
MF
MW
CM
A
CS
C
LP
D
FA
JS
MA
JK
BB
C
JV
FB
T
PB
CM
JC
DA
ほ
NN
BA
BM
TD
Y
DM
FR
VG
PD
MM
N
H
IC
S
Y
T
C
N
A
MT
ND
B
V
Y
A
K
A
HA
SY
YB
YÇ
Z
D
OA
CA
FG
RC
AV
DP
LW
D
RB
DŞ
MI
TF
EE
JM
CS
V
MS
SM
LM
JG
EP
DK
ML
JP
LF
MT
FC
WT
FH
MO
CN
CP
TL
P
JM
D
EB
OA
MT
PM
LS
TV
SG
F
AA
R
ID
RV
AA
LC
EO
AL
S
CE
JM
MP
SS
カカ
FT
S
DW
DQ